|
|
|
Medicines/Products by Categories |
|
|
|
 |
|
|
|
|
Unaudited Financial Results for the Quarter ended on 31st December, 2004
|
|
(RS. IN LACS) |
| PARTICULARS |
For the Quarter
ended
31.12.2004 |
For the Quarter
ended
31.12.2003 |
For Nine Months
ended
31.12.2004 |
For the Nine Months
Ended
31.12.2003 |
Year
Ended
31.03.2004 |
|
|
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Audited) |
| INCOME FROM OPERATIONS |
|
|
|
|
|
| SALES |
6400.12 |
5334.33 |
18169.41 |
15208.77 |
21183.70 |
| CONTRACT RESEARCH |
0.00 |
0.00 |
65.00 |
0.00 |
64.95 |
|
TOTAL (A) |
6400.12 |
5334.33 |
18234.41 |
15208.77 |
21248.65 |
| OTHER INCOME |
|
|
|
|
|
| PROFIT ON SALEOF
SHARES |
1050.68 |
32.18 |
1063.68 |
37.24 |
53.50 |
| OTHER INCOME |
13.71 |
10.49 |
37.40 |
24.98 |
125.38 |
|
TOTAL (B) |
1064.39 |
42.67 |
1101.08 |
62.22 |
178.88 |
|
|
|
|
|
|
|
| GRAND
TOTAL(A+B) |
7464.51 |
5377.00 |
19335.49 |
15270.99 |
21427.53 |
|
|
|
|
|
|
|
| TOTAL
EXPENDITURE |
5677.43 |
4802.67 |
16157.40 |
13663.42 |
19916.54 |
|
|
|
|
|
|
|
| DECREASE IN STOCK IN
TRADE |
1830.34 |
-327.82 |
1668.13 |
-602.14 |
-1884.50 |
| CONSUMPTION OF RAW
MATERIAL |
2996.41 |
4403.19 |
12004.28 |
12165.56 |
18108.87 |
| COST OF SALES |
4826.75 |
4075.37 |
13672.41 |
11563.42 |
16224.37 |
| STAFF COST |
190.48 |
178.28 |
552.50 |
481.97 |
696.55 |
| OTHER EXPENSES |
660.20 |
549.02 |
1932.49 |
1618.03 |
2341.92 |
| INTEREST |
155.51 |
139.72 |
457.32 |
451.43 |
558.71 |
| DEPRECIATION |
26.20 |
25.95 |
89.15 |
71.96 |
94.99 |
| PROFIT BEFORE
TAX |
1605.37 |
408.66 |
2631.62 |
1084.18 |
1510.99 |
| PROVISION FOR TAX |
41.60 |
30.65 |
118.57 |
81.31 |
124.07 |
| PROVISION FOR DEFFERRED
TAX |
111.25 |
60.99 |
170.64 |
76.73 |
100.91 |
| NET PROFIT |
1452.52 |
317.02 |
2342.41 |
926.14 |
1286.01 |
| PAID UP SHARE CAPITAL |
611.57 |
439.50 |
611.57 |
439.50 |
571.57 |
| RESERVES (EXCLUDING
REVALUATION RESERVES) |
---- |
---- |
---- |
---- |
6574.23 |
| E.P.S.(Rs.)BASIC |
23.75 |
7.21 |
38.30 |
21.07 |
23.44 |
|
|
NOTES: |
1. During the quarter under review, the net profit of the Company jumped by 358% as compared to the corresponding quarter of the previous year.
2. During the quarter, the Board of Directors of the Company, have allotted 15,00,000 Zero Coupon Optionally Convertible Warrants on preferential basis to promoters/directors of the Company and outside bodies corporate, in accordance with Section 81(1A) of the Companies Act, 1956 read with SEBI (Disclosure and Investor Protection) Guidelines on Preferential Issues.
3. The Company is exclusively in the Pharmaceutical business segment.
4. The Company has received 9 complaints during the quarter under review which were duly redressed to the satisfaction of the shareholders during the same quarter and as such, there were no pending complains as on 31st December, 2004.
5. The above financial results were taken on record by the Board at its meeting held on 22nd January, 2005. |
| |
|
By Order of the
Board |
| |
|
Sd/- |
| |
|
Dated: 22.01.2005 |
|
(Gopal Munjal) |
| |
|
Place: Chandigarh |
|
Chairman |
|
|
|
|